Warning letters to five US firms about unlawful claims for products labeled as containing delta-8 tetrahydrocannabinol were the Food and Drug Administration’s firsts about the ingredient but almost certainly won’t be the last and just as surely were late in coming.
The agency’s announcement and the warnings posted on 4 May, in addition to noting the firms’ violative drug and disease...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?